Trio Grup

Trio Grup

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Trio Grup is a prominent Turkish Contract Research Organization (CRO) established in 2010, offering end-to-end clinical trial management, observational studies, and data services to the biopharmaceutical industry. It leverages an experienced team to support national and international clients through complex regulatory environments and study execution. The company has demonstrated scientific contributions, with research accepted at major international congresses, and operates from a dedicated facility in Ankara.

OncologyHematology

Technology Platform

Integrated clinical research services platform including clinical trial management, observational studies, data management & statistics, and regulatory consulting, leveraging local Turkish expertise.

Opportunities

Growing demand for clinical trials in Turkey's large, treatment-naive patient population presents a significant opportunity.
Increased outsourcing by pharma and the need for real-world evidence studies further expands the addressable market for a local, full-service CRO.

Risk Factors

High geographic concentration in Turkey exposes the company to local political, economic, and regulatory instability.
Intense competition from both global multinational CROs and other local providers pressures pricing and necessitates continuous service differentiation.

Competitive Landscape

Competes in the Turkish CRO market against large global players (e.g., IQVIA, ICON) with vast resources and against other established local CROs. Differentiation is based on deep local regulatory expertise, personalized service, and cost-effectiveness.